About
Aligos Therapeutics is a biotechnology company developing novel therapeutic agents to treat significant liver diseases. The company is discovering and developing new classes of molecules that interact directly with disease causing modalities, such as viral encoded proteins and nucleic acids, as well as oncogenes and the resultant proteins in the case of our cancer indications. The company is also pursuing novel therapeutic agents aimed at activation of the patients’ immune system, in an effort to create lasting benefits for diseases that cause significant morbidity and mortality.